PRESS RELEASE November 12, 2011 - Recently, MSI received confirmation from the National Institute of Health (NIH) National Institute of General Medical Sciences (NIGMS) of a $2.3M SBIR Phase II Award to support the creation of an advanced pharmaceutical research […]

PRESS RELEASE Montara, California, October 30, 2011 - Today, Molecular Sensing, Inc. (MSI), a development stage biotechnology company, announced the issuance of a key U.S. patent that protects the company�s proprietary design for its Back-Scattering Interferometry (BSI) instruments. The patent […]

Drug discovery, New light on proteins. AT ANY given time, there are about 7,000 different types of protein molecule in the average human body cell. Almost a third of these are embedded in the cell’s outer membrane. Some control the […]

The on-line addition of Nature Biotechnology published “Label-free quantification of membrane-ligand interactions using backscattering interferometry” authored by Michael M Baksh, Amanda K Kussrow, Mauro Mileni, M G Finn & Darryl J Bornhop of The Scripps Institute and Vanderbilt University. The […]